Patent Assignment
Reel/Frame 026699/0236
Corrective Assignment to Correct the Assignor, Remove University of Utah Research Foundation as Assignor Previously Recorded on Reel 025553 Frame 0582. Assignor(S) Hereby Confirms the Transfer of Property Rights Made Between Inflabloc Pharmaceuticals, Inc. and Osiris Therapeutics, Inc..
Recorded: 2011-08-04
Pages: 14
Assignor
INFLABLOC PHARMACEUTICALS, INC
Executed: 2010-01-25
Assignee
OSIRIS THERAPEUTICS, INC.
7015 ALBERT EINSTEIN DRIVE, COLUMBIA, MARYLAND, 21046
Covered Property
(1)
Cobalamin Conjugates for Anti-Tumor Therapy
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 3, 2004
From: WEINSHENKER, NED M.; WEST, FREDERICK G.; ARANEO, BARBARA A.; LI, WEIPING
To: MANTICORE PHARMACEUTICALS, INC.
Reel/Frame 015417/0791 →
License
Dec 29, 2010
From: UNIVERSITY OF UTAH RESEARCH FOUNDATION; INFLABLOC PHARMACEUTICALS, INC.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 025553/0582 →
Merger
Aug 4, 2011
From: MANTICORE PHARMACEUTICALS, INC.
To: INFLABLOC PHARMACEUTICALS, INC.
Reel/Frame 026699/0351 →